Philadelphia, PA · Founded 2022 · Privately Held (backing)
Developer of a cell-based therapeutic platform intended to overcome bottlenecks in gene therapy manufacturing. BlueWhale Bio is based in Philadelphia, PA and was founded in 2022. It was valued at $52 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $23 million across 1 recorded round; the latest was a $5 million early-stage round in Oct 2025.
PMV mark · valuation
$52.0M
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$23.0M
Last round
Early Stage VC
Oct 2025
Team — not yet on record
No current team members for BlueWhale Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BlueWhale Bio with a free account
·Watch BlueWhale Bio: the Monday email on marks, rounds and moves
